Endoscopy 2003; 35(5): 383-387
DOI: 10.1055/s-2003-38768
Original Article
© Georg Thieme Verlag Stuttgart · New York

Methylene Blue Chromoendoscopy for the Detection of Barrett’s Esophagus in a Greek Cohort

G.  S.  Kouklakis 1 , J.  Kountouras 2 , S.  M.  Dokas 1 , E.  J.  Molyvas 3 , G.  P.  Vourvoulakis 1 , G.  I.  Minopoulos 4
  • 1 Dept. of Gastroenterology, 424 General Military Hospital, Thessaloniki, Greece
  • 2 Dept. of Medicine, Second Medical Clinic, Aristotle University, Ippokration Hospital, Thessaloniki, Greece
  • 3 Dept. of Pathology, 424 General Military Hospital, Thessaloniki, Greece
  • 4 Endoscopy Unit, Dept. of Surgery, Demokrition University of Thrace, Alexandroupolis, Greece
Further Information

Publication History

Submitted 23 August 2001

Accepted after Revision 27 November 2002

Publication Date:
17 April 2003 (online)

Preview

Introduction

Barrett’s esophagus is a premalignant condition defined as replacement of the normal distal esophageal epithelium by specialized columnar epithelium, characterized by the presence of goblet cells; it is also known as specialized intestinal metaplasia [1]. Affecting predominantly male white individuals, this disorder is found in 8-20 % of patients undergoing endoscopy for symptoms of gastroesophageal reflux [2]. It is associated with an increased risk of esophageal adenocarcinoma, with an estimated annual incidence of 0.5 % [3].

The classic definition of Barrett’s esophagus requires the presence of more than 3 cm of metaplastic epithelium proximal to the esophagogastric junction [4]. However, short segments of Barrett’s epithelium, less than 3 cm in length, are being reported with increasing frequency and have been implicated as a risk factor in the development of adenocarcinoma of the distal esophagus [5] [6] [7] [8]. Endoscopic diagnosis of this entity is difficult and always requires a histological demonstration of specialized columnar epithelium. Most endoscopists do not obtain biopsies unless the Barrett’s mucosa presents a specific salmon-pink appearance, so these short segments frequently go unrecognized. In addition, some authors have recently described the presence of intestinal metaplasia in normal-appearing esophagogastric junctions [7] [9]. The diagnosis of Barrett’s esophagus is therefore currently based on the histological finding of specialized intestinal metaplasia in any biopsy, regardless of the endoscopic appearance of the esophagus [7] [10].

Methylene blue is a dye that is taken up by metaplastic absorptive epithelium, such as intestinal-type metaplastic tissue in the stomach and esophagus [10] [11] [12] [13]. In contrast, it does not stain nonabsorptive epithelium, such as squamous or gastric mucosa [12]. Methylene blue appears to be highly accurate in the selective staining of specialized columnar epithelium of Barrett’s esophagus, and it has been recently suggested that methylene blue-directed biopsies could be used to improve endoscopic surveillance in patients with Barrett’s esophagus [14].

The aim of the present study was to assess the detection of suspected short-segment and long-segment Barrett’s esophagus in a large cohort of patients in Greece undergoing diagnostic upper gastrointestinal endoscopy, mainly due to gastroesophageal reflux disease (GERD) and/or dyspeptic symptoms. Methylene blue chromoendoscopy-directed biopsies were compared with biopsies obtained using conventional endoscopic criteria.

References

G. Kouklakis, M.D.

51 Androutsou St. · 55132 N. Krini · Thessaloniki · Greece

Fax: + 30-310-241941

Email: gastro@hol.gr